• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center


    DF/HCC / UMB partnership awarded $11 million by NCI

    Dana-Farber/Harvard Cancer Center and the University of Massachusetts Boston have been awarded $11 million over the next five years by the NCI to embolden their strong collaborative cancer research, training, and outreach program

    DF/HCC members receive top honors and awards

    A number of DF/HCC members have received top honors, awards, and distinctions since we published eNews last

    High-Throughput Polymorphism Detection Core

    The High-Throughput Polymorphism Detection Core (HTPC) provides services to DF/HCC investigators conducting molecular analyses of germline DNA collected as part of a wide range of investigations into the molecular epidemiology of cancer, including Genome Wide Association Studies (GWAS)

    Forty-five new members join DF/HCC

    Forty-five individuals have recently joined DF/HCC

    Phase 1b/2 trial targets stroma barrier in metastatic pancreatic cancer

    Pancreatic cancer has literally walled itself off for decades from efforts to find an effective drug therapy

    DF/HCC Collaborative RNAi Core offers new services

    The DF/HCC Collaborative RNAi Core is pleased to announce the availability of three new miRNA-targeted libraries and a new laser scanning cytometer

    Trials target abnormal fusion gene in lung cancer

    Non-small cell lung cancer (NSCLC), the most commonly fatal malignancy in the United States, accounts for approximately 85 percent of all lung cancer

Displaying results 92 to 98 out of 223